Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1007/s10549-023-07138-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
- (2022) Yukinori Ozaki et al. BMC CANCER
- Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
- (2022) José Á. García-Sáenz et al. CLINICAL CANCER RESEARCH
- The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer
- (2022) Cynthia X. Ma et al. CLINICAL CANCER RESEARCH
- Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis
- (2022) Jie Zhang et al. Human Cell
- Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
- (2022) Fábio Cardoso Borges et al. BREAST
- A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer
- (2022) Jose Alejandro Pérez-Fidalgo et al. Future Oncology
- Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway
- (2022) Lin He et al. PATHOLOGY RESEARCH AND PRACTICE
- Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway
- (2022) Shihao Di et al. Cell Death Discovery
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancer
- (2021) Niamh C. Cunningham et al. CANCER CELL
- HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells
- (2021) Belinda J. Petri et al. CANCER LETTERS
- Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial
- (2021) Guy Jerusalem et al. Clinical Breast Cancer
- A Novel Prognostic Signature of Immune-Related Long Noncoding RNA Pairs for Tumor-Infiltrating Immune Cells and Drug Susceptibility in Breast Cancer
- (2021) Shan Li et al. DNA AND CELL BIOLOGY
- The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis
- (2021) Yin Duan et al. MOLECULAR AND CELLULAR BIOLOGY
- Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy
- (2020) Francesca Reggiani et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
- (2020) Barry J. Thompson BIOESSAYS
- HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis
- (2020) Yanling Niu et al. CANCER RESEARCH
- The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
- (2020) Shuai Wang et al. Frontiers in Immunology
- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- LncRNA SNHG17 knockdown promotes Parkin-dependent mitophagy and reduces apoptosis of podocytes through Mst1
- (2020) Feng Guo et al. CELL CYCLE
- SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis
- (2020) Yang Liu et al. Cancer Cell International
- Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer
- (2019) Vassilis Aggelis et al. DRUGS
- Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
- (2019) Wen Ni et al. Molecular Cancer
- The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα
- (2017) Adrian Britschgi et al. NATURE
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression
- (2016) Jesse M. Engreitz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)
- (2014) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More